-
Scripta Therapeutics
Created in 2025
-
-
Trend leader (A+)
Existing signals make this entity one of the most dynamic startups -
Social networks
2,424 -
Activities
-
Technologies
-
Entity types
-
Location
Magdalen Centre, Robert Robinson Ave, Littlemore, Oxford OX4 4GA, UK
Oxford
United Kingdom
-
Employees
Scale: 11-50
Estimated: 20
-
Engaged catalyst
3
0 0 -
Added in Motherbase
7 months, 3 weeks ago
-
Value proposition
Biology decoded, disease undone
Scripta Therapeutics is an Oxford-based techbio company that takes a biology-first approach to discover disease-modifying drugs that modulate transcription factor activity and reprogram biology.
We aim to discover and develop therapeutics for neurodegenerative disorders. We are following a unique strategy, based on the concept that transcription factors, the master controllers of gene expression, are core drivers of disease and act as detailed and dynamic maps of disease. Therapeutics that modulate these maps to restore the healthy cell state can be efficiently identified by a data-rich, lab-in-the-loop combination of experimental biology with cutting-edge AI and informatics.
-
Scripta Therapeutics
Biology decoded, disease undone - modulating transcription factors to restore health
https://www.scriptatherapeutics.com/
| Catalyst | Type | Tweets | Articles | |
|---|---|---|---|---|
Sifted
Technology, Information and Media (Auto) |
Sifted
Technology, Information and Media (Auto) |
Other
31 May 2026 |
|
|
Oxford Science Enterprises
Startup accelerator & VC, Venture Capital and Private Equity Principals (Auto) |
Oxford Science Enterprises
Startup accelerator & VC, Venture Capital and Private Equity Principals (Auto) |
Other
31 May 2026 |
|
|
Oxford University Innovation
Research, Investment Management (Auto) |
Oxford University Innovation
Research, Investment Management (Auto) |
Other
18 Nov 2025 |
|
|